Sparian Biosciences Inc. has been awarded a $19.5 million, 5-year grant to fund development of SBS-226 from IND submission through phase I development. SBS-226 is a first-in-class dual μ-opioid ...
Contributor: From 2021 to 2024, a 40% Rise in Commercially Insured Patients with Opioid Use Disorder
An increase in opioid use disorder was found in those who had commercial insurance, with those aged 31 to 40 years having the highest percentage of opioid use disorder. The Opioid Tracker includes a ...
It’s no secret the opioid crisis remains a major public health concern in the United States. It was declared a public health emergency in 2017, and for multiple years following, nationwide overdose ...
READING, Pa. - The Council on Chemical Abuse (COCA) recently approved funding for programs and services aimed at helping prevent and treat opioid use disorder in Berks County. The contract allocations ...
The use of medication for opioid use disorder (MOUD) in older adults has increased over the years, yet disparities persist across patient subgroups, with men, Black and Hispanic individuals, rural ...
Brain volume and function are altered in individuals with opioid use disorder, a new Yale study finds. Using magnetic resonance imaging (MRI) and functional MRI (fMRI), researchers observed the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results